Should we consider ADPKD new targeted therapies in PKD2 patients? - Université de Bretagne Occidentale Access content directly
Conference Papers Year : 2016

Should we consider ADPKD new targeted therapies in PKD2 patients?

Domains

Immunology

Dates and versions

hal-01326928 , version 1 (06-06-2016)

Identifiers

Cite

Emilie Cornec-Le Gall, Marie-Pierre Audrézet, Eric Renaudineau, Maryvonne Hourmant, Christophe Charasse, et al.. Should we consider ADPKD new targeted therapies in PKD2 patients?. 53rd ERA-EDTA congress, May 2016, Vienna, Austria. ⟨10.1093/ndt/gfw141.02⟩. ⟨hal-01326928⟩
107 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More